DRDGOLD Stock Forecast, Price & News

DRDGOLD (NYSE:DRD) Frequently Asked Questions

Is DRDGOLD a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DRDGOLD in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DRDGOLD stock.
View analyst ratings for DRDGOLD or view top-rated stocks.

How has DRDGOLD's stock price been impacted by Coronavirus?

DRDGOLD's stock was trading at $6.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DRD stock has increased by 47.5% and is now trading at $8.88.
View which stocks have been most impacted by COVID-19.

Are investors shorting DRDGOLD?

DRDGOLD saw a decline in short interest in the month of October. As of October 29th, there was short interest totaling 480,300 shares, a decline of 31.7% from the October 14th total of 703,100 shares. Based on an average daily volume of 202,400 shares, the days-to-cover ratio is currently 2.4 days.
View DRDGOLD's Short Interest.

How often does DRDGOLD pay dividends? What is the dividend yield for DRDGOLD?

DRDGOLD announced a Semi-Annual dividend on Monday, September 13th. Shareholders of record on Thursday, September 23rd will be given a dividend of $0.216 per share on Thursday, October 7th. The ex-dividend date is Wednesday, September 22nd.
View DRDGOLD's dividend history.

Is DRDGOLD a good dividend stock?

DRDGOLD pays an annual dividend of $0.40 per share and currently has a dividend yield of 4.48%. DRD has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View DRDGOLD's dividend history.

What price target have analysts set for DRD?

1 brokerages have issued 1 year target prices for DRDGOLD's stock. Their forecasts range from $18.00 to $18.00. On average, they expect DRDGOLD's share price to reach $18.00 in the next twelve months. This suggests a possible upside of 102.7% from the stock's current price.
View analysts' price targets for DRDGOLD or view top-rated stocks among Wall Street analysts.

Who are DRDGOLD's key executives?

DRDGOLD's management team includes the following people:

• Daniël Johannes Pretorius, Chief Executive Officer, Executive Director & MD
• Adriaan Jacobus Davel, Chief Financial Officer & Executive Director
• Shalin Naidoo, Chief Information & Technology Officer
• Deon Thomas van der Mescht, Head-South African Operations
• Wilhelm Jacobus Schoeman, Executive Officer-Business Development

Who are some of DRDGOLD's key competitors?

Some companies that are related to DRDGOLD include Alamos Gold (AGI), First Majestic Silver (AG), Harmony Gold Mining (HMY), NovaGold Resources (NG), Centerra Gold (CGAU), Osisko Gold Royalties (OR), Eldorado Gold (EGO), MAG Silver (MAG), IAMGOLD (IAG), Coeur Mining (CDE), Seabridge Gold (SA), SilverCrest Metals (SILV), Sandstorm Gold (SAND), Orla Mining (ORLA) and Fortuna Silver Mines (FSM).
View all of DRD's competitors.

What other stocks do shareholders of DRDGOLD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DRDGOLD investors own include Harmony Gold Mining (HMY), Alamos Gold (AGI), Kinross Gold (KGC), SSR Mining (SSRM), B2Gold (BTG), Advanced Micro Devices (AMD), Gold Fields (GFI), Pan American Silver (PAAS), AngloGold Ashanti (AU) and Yamana Gold (AUY).

What is DRDGOLD's stock symbol?

DRDGOLD trades on the New York Stock Exchange (NYSE) under the ticker symbol "DRD."

Who are DRDGOLD's major shareholders?

DRDGOLD's stock is owned by many different institutional and retail investors. Top institutional investors include Van ECK Associates Corp (7.89%), Renaissance Technologies LLC (1.21%), BlackRock Inc. (0.54%), Virtus ETF Advisers LLC (0.17%), Marshall Wace LLP (0.07%) and Citadel Advisors LLC (0.00%).

Which institutional investors are selling DRDGOLD stock?

DRD stock was sold by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Renaissance Technologies LLC, Marshall Wace LLP, Jane Street Group LLC, Virtus ETF Advisers LLC, Citadel Advisors LLC, Advisor Group Holdings Inc., and BlackRock Inc..

Which institutional investors are buying DRDGOLD stock?

DRD stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Morgan Stanley, Rathbone Brothers plc, Royal Bank of Canada, Commonwealth Equity Services LLC, Schonfeld Strategic Advisors LLC, Banque Cantonale Vaudoise, and Veriti Management LLC.

How do I buy shares of DRDGOLD?

Shares of DRD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DRDGOLD's stock price today?

One share of DRD stock can currently be purchased for approximately $8.88.

How much money does DRDGOLD make?

DRDGOLD has a market capitalization of $767.76 million and generates $343.54 million in revenue each year.

How many employees does DRDGOLD have?

DRDGOLD employs 2,791 workers across the globe.

What is DRDGOLD's official website?

The official website for DRDGOLD is www.drdgold.com.

Where are DRDGOLD's headquarters?

DRDGOLD is headquartered at 1 Sixty Jan Smuts Building 2nd Floor - North Tower 160 Jan Smuts Avenue, Rosebank T3, 2193.

How can I contact DRDGOLD?

DRDGOLD's mailing address is 1 Sixty Jan Smuts Building 2nd Floor - North Tower 160 Jan Smuts Avenue, Rosebank T3, 2193. The basic materials company can be reached via phone at (711) 470-2600, via email at [email protected], or via fax at 27-86-524-3061.